title: Managing pregnant patients with inflammatory bowel disease: a difficult compromise.
authors.affiliation: IBD Centre, Thalion, Bratislava, Slovakia Insitute of Medical Biology, Genetics and Clinical Genetics, Medical Faculty of Comenius University, Bratislava, Slovakia zelinkova@thalion.sk.
authors.forename: Zuzana
authors.initials: Z
authors.lastname: Zelinkova
authors.affiliation: Department of Gastroenterology & Hepatology, Erasmus Medical Center, Rotterdam, the Netherlands.
authors.forename: Janneke C
authors.initials: JC
authors.lastname: van der Woude
mesh_terms: D000305:Adrenal Cortex Hormones / Q000009:adverse effects*; D000893:Anti-Inflammatory Agents / Q000009:adverse effects*; D016640:Diabetes, Gestational / Q000139:chemically induced*; D005260:Female; D006801:Humans; D015212:Inflammatory Bowel Diseases / Q000188:drug therapy*; D011247:Pregnancy
chemical_list: D000305:Adrenal Cortex Hormones; D000893:Anti-Inflammatory Agents